N. Ida

发表

Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.

K. Miwa, A. Sato, N. Ida, 1996, Biochemistry.

Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.

Noriyasu Kamei, Kozo Takayama, Mariko Morishita, 2008, Journal of controlled release : official journal of the Controlled Release Society.

Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.

N. Kamei, M. Takeda-Morishita, Shingo Kikuchi, 2013, Journal of pharmaceutical sciences.

Structural requirements of penetratin absorption enhancement efficiency for insulin delivery.

M. Morishita, K. Takayama, K. Isowa, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.

T. Yoneda, K. Moriyama, G. Mundy, 1993, Cancer research.

High levels of "complexed" interleukin-6 in human blood.

P. Sehgal, J. Kenney, A. Allison, 1992, The Journal of biological chemistry.

Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.

P. Forsythe, S. Stafford, N. Ida, 1996, American journal of respiratory and critical care medicine.

Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.

Y. Kakizawa, N. Ida, R. Nishio, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Cloning and nucleotide sequence of the aspartase gene of Escherichia coli W.

Y. Shimura, N. Ida, M. Tokushige, 1985, Nucleic acids research.

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

Hiroshi Yamamoto, N. Taniguchi, Yasuhiko Yamamoto, 2005, The Journal of clinical investigation.

Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection.

R. Romero, U. Santhanam, P. Sehgal, 1991, Cytokine.

Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis

T. Ishikawa, K. Yoshioka, S. Kakumu, 1993, Gastroenterologia Japonica.

Serum interleukin 6 levels in patients with chronic hepatitis B.

T. Ishikawa, K. Yoshioka, S. Kakumu, 1991, The American journal of gastroenterology.

Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.

M. Sakata, Y. Koishihara, K. Shimoya, 1995, The Journal of clinical endocrinology and metabolism.

Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells.

T. Nagaya, H. Seo, Y. Murata, 1996, The Journal of rheumatology.

Expression and regulation of monocyte chemoattractant protein‐1 by human eosinophils

K. Matsushima, T. Kasahara, Koji Ito, 1997, European journal of immunology.

Effects of natural human interleukin-6 on thrombopoiesis and tumor progression in tumor-bearing mice.

Y. Satoh, T. Okamoto, K. Moriya, 1994, Cancer letters.

Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock.

N. Ida, K. Yoshizawa, M. Naruto, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Detection of monocyte chemotactic and activating factor (MCAF) in normal blood and urine using a sensitive ELISA.

N. Ida, G. Kawano, S. Sakurai, 1994, Cytokine.

L-Aspartate-induced activation of aspartase.

N. Ida, M. Tokushige, 1985, Journal of biochemistry.

Detection of Monocyte Chemotactic and Activating Factor (MCAF) and Interleukin (IL)‐6 in Human Seminal Plasma and Effect of Leukospermia on These Cytokine Levels

Shinichi Itoh, N. Ida, F. Saji, 1995, American journal of reproductive immunology.

Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis.

Y. Matsuura, N. Ida, T. Shimazu, 1989, Biochemical and biophysical research communications.

An enzyme-linked immunosorbent assay for the measurement of human interleukin-6.

N. Ida, T. Kunitomo, M. Kohase, 1990, Journal of immunological methods.

Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

C. Masters, K. Unsicker, K. Beyreuther, 1997, Nature Medicine.

A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids.

N. Ida, T. Kunitomo, K. Hosoi, 1992, Journal of immunological methods.

Preparation of a superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo.

T. Uchiyama, H. Igarashi, K. Miwa, 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells

C. Masters, K. Beyreuther, C. Masters, 1996, FEBS letters.

Alzheimer's Disease βA4 Protein Release and Amyloid Precursor Protein Sorting Are Regulated by Alternative Splicing*

C. Masters, G. Multhaup, K. Beyreuther, 1996, The Journal of Biological Chemistry.

Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression

B Engvall, J Schröder, J. Pantel, 1999, Annals of neurology.

Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies

T. Bayer, K. Beyreuther, S. Weggen, 1999, Journal of neuroscience research.

A Sensitive Serodiagnosis of Hepatitis C Virus (HCV) Infection with Two Non‐Fused Peptides: Comparison of Antibody Responses Detected with a Newly Developed Assay and a Commercial Second‐Generation Test

T. Arima, Kazuhiro Tanahashi, A. Sato, 1993, Microbiology and immunology.

Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.

N. Ida, Yoichiro Koshi, Taisuke Hirano, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Sensitive Enzyme‐Linked Immunosorbent Assays for the Detection of Bacterial Superantigens and Antibodies against Them in Human Plasma

H. Igarashi, K. Miwa, N. Ida, 2000, Microbiology and immunology.